Tracking the History of Tucatinib for Breast Cancer Treatment at SABCS
Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.
Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.
The AACR Industry Roundtable 2024 focused on topics related to tracking and treating early cancers, including predicting cancer risk...
Janet Mosugu, recipient of the Margaret Foti Scholarship, wants to use communication to help empower communities take charge of...
The 16th Frontiers in Cancer Science conference in Singapore includes a thematic focus on immuno-oncology, genomics, metabolism, and AI.
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Andrew Chapman and Kuang-Yi Wen of Thomas Jefferson University were named scientific awardees for their work in geriatric oncology...
By Bob Riter, Patient Advocate, Cornell Community Cancer Partnership When I was diagnosed with stage 2 breast cancer about...
Changes to sexual health during breast cancer treatment can impact quality of life and treatment adherence—especially in Black women.
The AACR Special Conference: Liquid Biopsy features experts exploring all facets of this exciting technological arena.
When Corrie Painter was diagnosed with angiosarcoma, an aggressive cancer in cells that line blood and lymph vessels, in...
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.